2. Academic Validation
  3. Appropriate dosing of burosumab in tumor-induced osteomalacia

Appropriate dosing of burosumab in tumor-induced osteomalacia

  • Osteoporos Int. 2022 Dec 1. doi: 10.1007/s00198-022-06617-2.
Luciano Colangelo 1,  Chiara Sonato 1,  Mara Riminucci 2,  Alessandro Corsi 3,  Salvatore Minisola 1
Affiliations

Affiliations

  • 1 Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
  • 2 Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • 3 Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. [email protected].
PMID: 36454246 DOI: 10.1007/s00198-022-06617-2
Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-P9939
    FGF23 Neutralizing Antibody